Mathieu Verdurand

798 total citations
26 papers, 517 citations indexed

About

Mathieu Verdurand is a scholar working on Cellular and Molecular Neuroscience, Physiology and Pharmacology. According to data from OpenAlex, Mathieu Verdurand has authored 26 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Physiology and 8 papers in Pharmacology. Recurrent topics in Mathieu Verdurand's work include Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Mathieu Verdurand is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Mathieu Verdurand collaborates with scholars based in France, Australia and United Kingdom. Mathieu Verdurand's co-authors include Luc Zimmer, Katerina Zavitsanou, Didier Le Bars, Thierry Billard, Victoria S. Dalton, Fabien Chauveau, Laëtitia Lemoine, Anne Bérod, Adrian Newman‐Tancredi and Marie‐Claude Grégoire and has published in prestigious journals such as PLoS ONE, Chemical Communications and Brain Research.

In The Last Decade

Mathieu Verdurand

26 papers receiving 512 citations

Peers

Mathieu Verdurand
Laurent Galineau France
Dileep Kumar United States
Salvador Sierra United States
Michael L. Himes United States
L. Oreland Sweden
Shai Porat United States
Jeff Meyer Canada
Agnete Dyssegaard Denmark
Brendon Binneman United States
Beata Planeta United States
Laurent Galineau France
Mathieu Verdurand
Citations per year, relative to Mathieu Verdurand Mathieu Verdurand (= 1×) peers Laurent Galineau

Countries citing papers authored by Mathieu Verdurand

Since Specialization
Citations

This map shows the geographic impact of Mathieu Verdurand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Verdurand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Verdurand more than expected).

Fields of papers citing papers by Mathieu Verdurand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Verdurand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Verdurand. The network helps show where Mathieu Verdurand may publish in the future.

Co-authorship network of co-authors of Mathieu Verdurand

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Verdurand. A scholar is included among the top collaborators of Mathieu Verdurand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Verdurand. Mathieu Verdurand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verdurand, Mathieu, Sophie Dautricourt, Virginie Desestret, et al.. (2025). Toward alpha‐synuclein seed amplification assay in clinical practice. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(1). e70066–e70066. 5 indexed citations
2.
Verdurand, Mathieu, et al.. (2022). Charge detection mass spectrometry on human-amplified fibrils from different synucleinopathies. Chemical Communications. 58(51). 7192–7195. 4 indexed citations
3.
Fourier, Anthony, Aline Dorey, Sergio Muñiz‐Castrillo, et al.. (2021). Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis. Journal of Neurology. 269(1). 377–388. 12 indexed citations
4.
Dauphinot, Virginie, Mathieu Verdurand, Floriane Delphin‐Combe, et al.. (2019). Impact of Cognitive, Functional, Behavioral Disorders, and Caregiver Burden on the Risk of Nursing Home Placement. Journal of the American Medical Directors Association. 20(10). 1254–1262. 30 indexed citations
5.
Dauphinot, Virginie, Isabelle Rouch, Mathieu Verdurand, et al.. (2019). A multicenter cohort study to investigate the factors associated with functional autonomy change in patients with cognitive complaint or neurocognitive disorders: the MEMORA study protocol. BMC Geriatrics. 19(1). 191–191. 10 indexed citations
6.
Verdurand, Mathieu, Sophie Lancelot, Waël Zeinyeh, et al.. (2018). Amyloid-Beta Radiotracer [18F]BF-227 Does Not Bind to Cytoplasmic Glial Inclusions of Postmortem Multiple System Atrophy Brain Tissue. Contrast Media & Molecular Imaging. 2018. 1–7. 16 indexed citations
7.
Verdurand, Mathieu & Luc Zimmer. (2017). Hippocampal 5-HT1A receptor expression changes in prodromal stages of Alzheimer's disease: Beneficial or deleterious?. Neuropharmacology. 123. 446–454. 27 indexed citations
8.
Vidal, Benjamin, Mathieu Verdurand, Thierry Billard, et al.. (2016). Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer’s disease: A post-mortem study with PET radiopharmaceuticals. Neuropharmacology. 109. 88–95. 32 indexed citations
9.
Verdurand, Mathieu, Fabien Chauveau, Frédéric Bonnefoi, et al.. (2015). Differential effects of amyloid-beta 1–40 and 1–42 fibrils on 5-HT 1A serotonin receptors in rat brain. Neurobiology of Aging. 40. 11–21. 27 indexed citations
10.
Lancelot, Sophie, Caroline Bouillot, Fabien Chauveau, et al.. (2014). Binding of the PET Radiotracer [<sup>18</sup>F]BF227 Does not Reflect the Presence of Alpha-Synuclein Aggregates in Transgenic Mice. Current Alzheimer Research. 11(10). 955–960. 16 indexed citations
11.
Verdurand, Mathieu, Stu G. Fillman, Cynthia Shannon Weickert, & Katerina Zavitsanou. (2013). Increases in [3H]Muscimol and [3H]Flumazenil Binding in the Dorsolateral Prefrontal Cortex in Schizophrenia Are Linked to α4 and γ2S mRNA Levels Respectively. PLoS ONE. 8(1). e52724–e52724. 17 indexed citations
12.
Nguyen, Vu H., Hongqin Wang, Mathieu Verdurand, & Katerina Zavitsanou. (2012). Differential Treatment Regimen-Related Effects of HU210 on CB<sub>1</sub> and D<sub>2</sub>-Like Receptor Functionality in the Rat Basal Ganglia. Pharmacology. 89(1-2). 64–73. 2 indexed citations
13.
Nguyen, Vu H., Mathieu Verdurand, Stefanie Dedeurwaerdere, et al.. (2011). Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: A small animal PET imaging study with 18F-FDG. Brain Research Bulletin. 87(2-3). 172–179. 14 indexed citations
14.
Lemoine, Laëtitia, et al.. (2010). Looking for a 5-HT7 radiotracer for positron emission tomography. Bioorganic & Medicinal Chemistry Letters. 20(12). 3730–3733. 18 indexed citations
15.
Verdurand, Mathieu, Anne Bérod, Didier Le Bars, & Luc Zimmer. (2009). Effects of amyloid-β peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus. Neurobiology of Aging. 32(1). 103–114. 26 indexed citations
16.
Lemoine, Laëtitia, Mathieu Verdurand, Bernard Vacher, et al.. (2008). Synthesis, fluorine-18 labelling and radiopharmacological evaluation of F15599, a novel 5-HT1A receptor agonist. 49(6). 463–70. 4 indexed citations
17.
Verdurand, Mathieu, et al.. (2008). Automated radiosynthesis of the Pittsburg compound-B using a commercial synthesizer. Nuclear Medicine Communications. 29(10). 920–926. 23 indexed citations
18.
Desbrée, Aurélie, Mathieu Verdurand, Jérémy Godart, et al.. (2008). The Potential of a Radiosensitive Intracerebral Probe to Monitor 18F-MPPF Binding in Mouse Hippocampus In Vivo. Journal of Nuclear Medicine. 49(7). 1155–1161. 4 indexed citations
19.
Verdurand, Mathieu, Benoı̂t Joseph, Laëtitia Lemoine, et al.. (2007). Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligand. Nuclear Medicine and Biology. 34(8). 995–1002. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Galineau Breakdown of academic impact, for papers by Dileep Kumar Breakdown of academic impact, for papers by Salvador Sierra Breakdown of academic impact, for papers by Michael L. Himes Breakdown of academic impact, for papers by L. Oreland Breakdown of academic impact, for papers by Shai Porat Breakdown of academic impact, for papers by Jeff Meyer Breakdown of academic impact, for papers by Agnete Dyssegaard Breakdown of academic impact, for papers by Brendon Binneman Breakdown of academic impact, for papers by Beata Planeta
Rankless by CCL
2026